Methyl-lysine reader domain (Kme reader)

Methyl-lysine reader domains are specialized protein modules that recognize and bind to methylated lysine residues on histone tails and non-histone proteins, serving as critical effectors in epigenetic signaling. These domains, which include the Tudor, Chromo, PHD finger, MBT, PWWP, and WD40 repeat families, typically utilize a conserved aromatic cage to anchor the methyl-ammonium group of the lysine through cation-π interactions. By interpreting specific methylation marks (e.g., H3K4me3 or H3K27me3), these readers recruit chromatin-remodeling complexes and transcriptional machinery to regulate gene expression, DNA repair, and cell cycle progression. Dysregulation of these domains is frequently linked to oncogenesis, where they can drive the expression of oncogenes like Myc or suppress tumor suppressors. Consequently, they have emerged as significant therapeutic targets, with small-molecule inhibitors and PROTACs being developed to disrupt their interaction with methylated substrates. Targeting these domains offers a strategy to reprogram the epigenetic landscape in diseases such as leukemia, solid tumors, and neurodevelopmental disorders.

Other names

Lysine methylation readerHistone methyl-lysine readerKme reader domainMethyl-lysine binding domainRoyal family domainPHD finger

Competitive inhibition of the methyl-lysine binding pocket (aromatic cage) to prevent the recruitment of effector proteins to specific chromatin marks.